Document Detail

Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing their first treatment cycle of IVF or ICSI.
MedLine Citation:
PMID:  20602599     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To test whether the clinical efficiency of recombinant FSH (rFSH) and highly purified human menotrophin (hMG) differs in terms of pregnancy and live birth rates during the first treatment cycle of IVF or ICSI. DESIGN: Prospective cohort study. SETTING: Department of Gynecology and Obstetrics, Rikshospitalet, Oslo University Hospital. STUDY POPULATION: Records of 1,136 infertile couples undergoing their first IVF (n = 682) or ICSI (n = 454) treatments were reviewed. The effect of hMG and rFSH was analyzed for the IVF and ICSI groups separately. METHODS: Patients received long term down-regulation with GnRH agonist and controlled ovarian hyperstimulation with hMG or rFSH. Oocytes were fertilized by IVF or ICSI. Embryos were transferred on Day 2. MAIN OUTCOME MEASURES: Primary outcome measures were pregnancy and live birth rates, secondary outcome measures were duration of treatment, doses of hMG or rFSH applied, number of oocytes retrieved and the number and quality of embryos obtained. RESULTS: Similar pregnancy and live birth rates were observed with hMG and rFSH. Compared to hMG, treatment cycles with rFSH were characterized by significantly shorter stimulation, lower gonadotrophin consumption, and increased number of oocytes and embryos. CONCLUSION: We conclude that rFSH and hMG are equivalent in terms of clinical efficacy.
Sverre Bjercke; Tom Tanbo; Thomas Abyholm; Anne Omland; Hans Kristian Opøien; Peter Fedorcsak
Related Documents :
10683599 - Exercise and training in women, part ii: influence of menstrual cycle and pregnancy.
18567899 - What is the most accurate estimate of pregnancy rates in ivf dropouts?
8290179 - The temporal relation between the urine lh surge and sonographic evidence of ovulation:...
15567879 - Timing ovulation for intrauterine insemination with a gnrh antagonist.
3556619 - Prediction of ovulation with the use of oral and vaginal electrical measurements during...
12521809 - The potential effect of controlled ovarian hyperstimulation on follicular vascular perf...
3679859 - Myocardial infarction during pregnancy: a team challenge.
16725539 - Non-surgical embryo transfer in cattle embryo-recipient interactions.
11641669 - A randomized controlled trial comparing oxytocin administration before and after placen...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta obstetricia et gynecologica Scandinavica     Volume:  89     ISSN:  1600-0412     ISO Abbreviation:  Acta Obstet Gynecol Scand     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-19     Completed Date:  2010-08-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370343     Medline TA:  Acta Obstet Gynecol Scand     Country:  England    
Other Details:
Languages:  eng     Pagination:  1053-60     Citation Subset:  IM    
Department of Obstetrics and Gynecology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Buserelin / therapeutic use
Embryo, Mammalian
Fertility Agents, Female / therapeutic use*
Fertilization in Vitro
Follicle Stimulating Hormone / therapeutic use*
Hormones / therapeutic use*
Live Birth*
Menotropins / therapeutic use*
Ovulation Induction / methods*
Pregnancy Rate*
Prospective Studies
Sperm Injections, Intracytoplasmic
Time Factors
Reg. No./Substance:
0/Fertility Agents, Female; 0/Hormones; 57982-77-1/Buserelin; 61489-71-2/Menotropins; 9002-68-0/Follicle Stimulating Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Abstracts.
Next Document:  Early postpartum hysterectomy: incidence and risk factors.